This advanced flow cytometer sorts and analyses thousands of cells in real-time based on their surface markers and internal features. In precision medicine, it helps researchers and clinicians identify rare or diseased cells, such as cancerous or immune cells, to develop more accurate diagnostics and customised treatments.

Using spectral flow cytometry, Cytek Aurora detects a broad range of cellular markers with high accuracy, enabling a more detailed understanding of complex cell populations. In precision medicine, it plays a key role in identifying subtle differences between healthy and diseased cells, aiding in the development of more tailored immunotherapies and targeted treatments.

This technology combines high resolution microscopy with whole transcriptome analysis of up to 20,000 genes simultaneously, allows researchers to spatially map and uncover the unique roles of different cells in tissues. In precision medicine, it enables a deeper understanding of how diseases like cancer or autoimmune disorders develop and progress, leading to more targeted and effective treatments.

Xenium maps gene activity at unprecedented resolution within tissue samples while maintaining the spatial arrangement of cells, revealing how genes and cells function and interact in their natural environment. This is crucial for precision medicine, as it helps identify specific cellular behaviours and disease markers, leading to more personalised therapies for conditions such as cancer and neurological disorders.

BD Rhapsody captures and analyses RNA from individual cells, providing a detailed snapshot of cellular activity and gene expression. This is essential for precision medicine, as it helps pinpoint molecular drivers of diseases, allowing for highly personalised treatment strategies, such as customised cancer immunotherapies.

This digital PCR system accurately quantifies genetic material by dividing samples into tiny droplets for precise molecular analysis. In precision medicine, it is used to detect genetic mutations, monitor disease progression, and tailor treatments to a patient’s unique genetic profile, improving outcomes in cancer, infectious diseases, and genetic disorders.